| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |